Serum total cholesterol as mortality predictor for hospital-acquired acute kidney injury

QIAN Jing,MA Shuai,CHEN Yingying,YOU Huaizhou,LIU Junfeng,KUANG Dingwei,GU Yong,HAO Chuanming,DING Feng

2013-01-01

Abstract:Objective To evaluate the value of serum total cholesterol for prediction of 90-day mortality acute kidney injury (AKI) patients. Methods In a prospective cohort study, 176 hospital-acquired AKI patients were enrolled into low cholesterol group (<2.8 mmol/L) and high cholesterol group (≥2.8 mmol/L) when they were diagnosed as AKI. All patients were followed up for 90 days. Results The mean serum total cholesterol was (3.61±1.49) mmol/L. There were 48 patients (27.3%) with hypocholesterolemia (<2.8 mmol/L). The case fatality rate in low cholesterol group and high cholesterol group were 54.2% (26/48) and 32.8% (42/128), respectively. Kaplan-Meier survival analysis showed that there was significant difference in survival curve between the two groups (P=0.006). Cox risk regression model showed that hypocholesterolemia was one of the independent predictors for death in 90 days after AKI. Logistic regression model receptor oriented curve showed that area under curve (AUC) was 0.588 (95%CI: 0.489-0.687) for total cholesterol. Conclusion Serum total cholesterol can be taken as a 90-day mortality predictor in hospital-acquired acute kidney injury.